Protagonist Therapeutics, Inc. (PTGX) Social Stream



Protagonist Therapeutics, Inc. (PTGX): $31.95

0.99 (+3.20%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Protagonist Therapeutics Inc (PTGX) Price Targets From Analysts

Use the tables below to see what analysts covering Protagonist Therapeutics Inc think about its future price and what recommendations they have for investors and traders.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
4 $37 $27 $31.75 $29.69 6.94%

Over the past 154 days, PTGX's average upside potential has been 62.99%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2020-10-21 4 37 27 31.75 19.48 62.99%
2020-09-17 4 37 27 31.75 NA NA%
2020-08-07 4 37 27 30.50 NA NA%
2020-07-22 4 30 19 26.00 NA NA%
2020-07-15 4 30 19 26.00 NA NA%
2020-07-09 3 33 28 30.33 NA NA%
2020-05-20 4 33 17 27.00 NA NA%

PTGX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.44 3 3 2 0 0 8

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • The upside potential (average analyst target price relative to current price) of PTGX is greater than 30.88% of all US stocks.
  • Protagonist Therapeutics Inc's number of analysts covering the stock is greater than 19.35% of stocks in the mid market cap category.
  • The average analyst price target of PTGX is greater than 64.01% of Pharmaceutical Products stocks.
  • Protagonist Therapeutics Inc's variance in analysts' estimates is less than 62.75% of Pharmaceutical Products stocks.

In the Pharmaceutical Products industry, SNDX, BLU and RXRX are the three stocks most similar to Protagonist Therapeutics Inc regarding the price target and analyst recommendation information presented here.

Is PTGX a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6407 seconds.